The LHX3 LIM homeodomain transcription factor is required for pituitary development and motor neuron specification. The Lhx3 gene encodes two isoforms, LHX3a and LHX3b, that differ in their amino-terminal sequences. Humans and mice with defective Lhx3 genes are deficient in gonadotrope, lactotrope, somatotrope, and thyrotrope pituitary cells. We show that, whereas Lhx3b is highly expressed in these Lhx3-dependent cell types, high levels of Lhx3a expression are restricted to ␣ glycoprotein subunit-expressing thyrotropes and gonadotropes. Cross-species comparison reveals the LHX3b-specific domain is more conserved than the LHX3a-specific domain. We demonstrate that the LHX3b-specific domain is a transferable inhibitor that reduces gene activation and DNA binding by homeodomain proteins. In addition, we identify a novel LHX3 protein (M2-LHX3) and determine that this molecule is generated by an internal translation initiation codon. The LHX3a-and LHX3b-specific coding sequences regulate differential usage of this internal start codon. Further, we identify the major activation domain of LHX3 in the carboxyl terminus of the molecule. M2-LHX3 is active because it retains this domain and binds DNA better than LHX3a or LHX3b. Other LIM homeodomain genes, including Lhx4, generate similar truncated proteins. These studies describe how transcriptional regulatory genes can generate multiple functional proteins.
DNA sequencing projects have revealed that the human genome consists of approximately one third of the previously estimated total number of genes (1) . Because of the limited number of human genes, it is likely that multiple strategies are used to generate proteins with sufficient regulatory capacity to coordinate cellular processes such as developmental and metabolic programs. The production of multiple proteins from a single gene vastly increases the functional complexity of the genome. Combinations of alternative RNA splicing, multiple promoter usage, RNA editing, alternate sites of translation initiation, and post-translational modifications enable expression of the genome to diverse "proteomes" necessary for the generation of unique cell types and tissues.
LIM homeodomain (HD) 1 transcription factors comprise a subfamily of HD proteins that contain two amino-terminal zinc finger-like LIM motifs, which mediate interactions with other transcription factors and co-regulatory proteins, and a characteristic DNA-binding HD. Gene targeting experiments in mice have demonstrated that LIM HD class transcription factors regulate many aspects of mammalian organogenesis and are critical to cell lineage specification processes (2) . For example, the LHX3 and LHX4 LIM HD proteins are essential for proper development of the anterior lobe of the pituitary gland. These factors are necessary for the differentiation and proliferation of the specific anterior pituitary cell types (3) . The Lhx3 gene alone may control several aspects of these processes because it codes for two alternate isoforms, LHX3a and LHX3b (4 -7).
The anterior pituitary gland is composed of specialized cell types that control endocrine homeostasis by secreting hormones in a regulated fashion. The cell types of the mature gland are somatotropes that secrete GH, thyrotropes that release TSH, lactotropes that produce PRL, gonadotropes that synthesize luteinizing hormone and follicle-stimulating hormone, and corticotropes that secrete adrenocorticotropin. To form the pituitary gland and differentiate these cell types, neural ectoderm of the ventral diencephalon must first associate with a fold of ectoderm from the developing oral cavity. These early events, which establish the primordial pituitary structure known as Rathke's pouch, require the actions of both the LHX3 and LHX4 transcription factors. The developing pituitaries of mice lacking both the Lhx3 and Lhx4 genes fail to progress beyond the rudimentary pouch stage (3) . Upon formation of this rudimentary pituitary, Lhx3 is required for formation of a definitive Rathke's pouch, pituitary cell commitment, and the emergence of the hormone-secreting cell lineages. In Lhx3 knockout mice, pituitary development is arrested after the initial formation of Rathke's pouch, and the differentiated hormone-secreting cells, with the exception of a few corticotropes, are absent (8) . Interestingly, the phenotype of Lhx3 null mice is consistent with the clinical description of human patients with mutations in this gene; these patients display combined pituitary hormone deficiency but possess normal corticotrope function (9) . Together, these studies indicate that Lhx3 is critical for both early structural events and for the specification and proliferation of the gonadotrope, lactotrope, somatotrope, and thyrotrope pituitary cell lineages.
The Lhx3 gene produces two isoforms, LHX3a and LHX3b, that contain common LIM domains, HD, and carboxyl-terminal sequences but possess alternate amino-terminal domains (4 -7) . We have shown previously that the LHX3a isoform activates specific pituitary target genes, alone or in combination with the pituitary POU HD domain factor PIT-1, more effectively than the LHX3b isoform (5) . The differences in the gene activation properties of these factors correlate with their abilities to bind DNA regulatory elements; the b-specific domain inhibits DNA binding of LHX3 to specific DNA sites (5) . Here, we investigate the regulatory properties of the LHX3a-and LHX3b-specific domains. The LHX3b-specific domain sequence is highly conserved in mammals. The Lhx3a and Lhx3b isoforms are differentially expressed in specialized pituitary cell types, suggesting cell-specific functions. The LHX3b-specific domain is a transferable inhibitory domain that can repress the function of HD transcription factors. In addition, we describe a novel, functional LHX3 molecule, M2-LHX3, that is specifically expressed from the Lhx3a transcript in pituitary cell lines, and examine the alternate protein translation mechanism utilized to generate this isoform. M2-LHX3 binds DNA regulatory elements better than LHX3a and LHX3b, and it utilizes a previously uncharacterized activation domain within its carboxyl terminus to induce transcription. The Lhx4 gene also produces an equivalent alternate protein, and we propose that other members of the LIM HD class of developmental regulatory genes use similar strategies to increase their coding capacities.
EXPERIMENTAL PROCEDURES

Lhx3
Isoform Cloning from Mammalian Species-Total RNA was extracted from rat, pig, and guinea pig pituitaries using Tri-Reagent (Molecular Research Center, Inc., Cincinnati, OH) as described previously (5). Rhesus monkey pituitary RNA was a kind gift from Dr. T. Golos (Wisconsin Regional Primate Research Center). Complementary DNA was synthesized from RNAs using Superscript II reverse transcriptase (Life Technologies, Inc.) and 5Ј-ta(g/a)aggatcaa(g/a)cggtcca-3Ј as a primer. PCR then was performed using the following primers: 5Ј-(t/c)gg(a/c)(t/c)t(a/g)gtg(a/g)c(t/c)gc(c/g)atg-3Ј (5Ј, Lhx3a), 5Ј-cc(a/g)(a/ g)c(a/g)(c/g)c(t/c/g)gg(c/a)cccatg-3Ј (5Ј, Lhx3b), and 5Ј-tggtc(g/a)cagcc(g/ a)gc(a/g)cacag-3Ј (3Ј, Lhx3a/b). Cycling parameters were as follows: 94°C 30 s, 62-56°C 30 s, 72°C 1 min, for 30 cycles. PCR products were ligated into pCRII-TOPO (Invitrogen, Carlsbad, CA) and sequenced on both strands by automated DNA sequencing (Biochemistry Biotechnology Facility, Indiana University, Indianapolis, IN). Gene sequences were assembled and aligned using the Wisconsin Genetics GCG computer package.
Lhx3 Isoform Expression in Pituitary Cell
Lines-Analysis of Lhx3a and Lhx3b expression in rodent pituitary cell lines was as described (5) . cDNA was synthesized from ␣T3-1 (kind gift of Dr. S. Camper, University of Michigan, Ann Arbor, MI), 235-1, and GC RNA, and PCR reaction products were analyzed on 11% acrylamide Tris borate gels.
Expression Vector Construction and Site-directed Mutagenesis-Myc epitope-tagged human LHX3a, LHX3b, and PROP-1 expression vectors were previously described (5, 10). The mouse LHX4 cDNA was cloned from GHFT1-5 RNA (data not shown). These cDNAs were used as templates in PCR experiments to generate Myc epitope-tagged a-LHX3b, b-LHX3a, ⌬N-LHX3, and a-and b-domain-PROP-1, a-and b-domain-LHX4, and a-and b-domain-TEF expression vectors by cloning compatible cDNA fragments into pcDNA3.1/Myc-His(Ϫ)C (Invitrogen). Gal4 DNA binding domain (Gal4-DB)-LHX3 domain expression vectors were generated by cloning compatible cDNA fragments into pcDNA stop -Gal4-DB (a gift from Dr. S. Konieczny, Purdue University, West Lafayette, IN). DNA fragments were generated by PCR using Pfu polymerase (Stratagene, La Jolla, CA). Site-directed mutagenesis was performed using QuikChange (Stratagene). Oligonucleotide primer sequences will be provided upon request. The integrity of all plasmids was confirmed by DNA sequencing.
Cell Culture, Transfection, and Luciferase Assays-Pituitary cells and embryonic kidney 293T cells were cultured as described (5). 1.5 ϫ 10 5 293T cells/60-mm dish were transfected with calcium phosphate-DNA precipitates using the CalPhos system (CLONTECH, Palo Alto, CA). 0.5 g of reporter plasmid and 0.1-1.0 g of expression vector were added per 60-mm dish, and all groups received equal final DNA concentrations. Control cultures received empty expression vector DNA. The murine ␣ glycoprotein subunit (␣GSU) luciferase plasmid (11) was a kind gift of Dr. R. Maurer (Oregon Health Sciences University, Portland, OR). The 5ϫ Gal upstream activating sequence luciferase reporter plasmid was a gift from Dr. A. Russo (University of Iowa, Iowa City, IA). Use of the murine thyroid-stimulating hormone ␤ subunit (TSH␤) luciferase (12), PRDQ 9 reporter gene (10), rat PRL promoter (13) , and rat PIT-1 (13) plasmids have been described. Luciferase activity was measured 48 h after transfection as described (13) . All assay points were performed in triplicate. Total cell protein was determined by the Bradford method (Bio-Rad), and luciferase activity was normalized to protein concentration.
Western Analysis-Western analysis of 293T cells transfected with expression vectors was previously described (13) . Mouse anti-Myc 9E10 ascites fluid (Developmental Studies Hybridoma Bank, University of Iowa, Iowa City, IA) was used at 1:5,000. The secondary antibody was goat anti-mouse/horseradish peroxidase (Sigma) used at 1:15,000. Results were visualized using Lumi-Light PLUS chemiluminescence reagents (Roche Molecular Biochemicals) and exposure to Biomax MR film (Eastman Kodak Co.).
In Vitro Transcription/Translation-Radiolabeled human LHX3a, LHX3b, ⌬N-LHX3, a-LHX3b, b-LHX3a, PROP-1, a-PROP-1, and b-PROP-1 proteins were synthesized in vitro from pcDNA3.1/Myc-His(Ϫ)C expression vector substrates using T7 RNA polymerase, TnT rabbit reticulocyte lysates (Promega, Madison, WI), and [
35 S]methionine (Amersham Pharmacia Biotech). Proteins were analyzed using SDS-PAGE followed by treatment with Amplify fluorography reagent (Amersham Pharmacia Biotech) and exposure to Biomax MR film or a Storm phosphorimager screen (Molecular Dynamics, Sunnyvale, CA).
Recombinant Protein Preparation-Bacterial expression vectors for glutathione S-transferase (GST)-LHX3a and GST-LHX3b fusion proteins were previously described (5). GST-a-LHX3b, GST-b-LHX3a, GST-⌬N-LHX3, and GST-M2-LHX3 vectors were constructed by cloning cDNAs into pGEX-KT. Recombinant proteins were expressed in Escherichia coli BL21 (DE3) pLysS and affinity-purified as described previously (13) . Proteins were analyzed on 12% SDS-PAGE gels followed by staining with Coomassie Brilliant Blue.
Electrophoretic Mobility Shift Analysis (EMSA)-EMSA were performed as described (13) using purified recombinant proteins, in vitro translated proteins (5), nuclear extracts, or whole cell extracts (14) . Total protein was determined by the Bradford method. Oligonucleotides representing the pituitary glycoprotein hormone basal element (PGBE) base pair Ϫ350 to Ϫ323 region of the murine ␣GSU promoter (5Ј-acattaggtacttagctaattaaatgtg-3Ј and 5Ј-cacatttaattagctaagtacctaatgt-3Ј), the LHX3 consensus binding site (5Ј-gatcccagaaaattaattaattgtaa-3Ј and 5Ј-gatcttacaattaattaattttctgg-3Ј), or the PRDQ 9 site (5Ј-tccgactaattgaattagcgaga-3Ј and 5Ј-tctcgctaattcaattagtcgga-3Ј) were used as radiolabeled probes. Anti-LIM-3/LHX3 (Chemicon, Temecula, CA) or antiMyc antibodies were added to confirm the specificity of interactions.
RESULTS
The Amino Acid Sequence of the LHX3b-specific Domain Is Highly Conserved in Mammals-To examine conservation of the alternate LHX3 amino-terminal domains, we used degenerate RT-PCR to clone cDNAs coding for these domains from several mammals. By contrast to the Lhx3/LIM-3 genes of non-mammalian species, which have not been reported to encode multiple protein isoforms, LHX3a-and LHX3b-specific domains were identified in the rhesus monkey, pig, rat, and guinea pig (LHX3b only) (Fig. 1A) . The LHX3b-specific domains from the species examined are more similar in length, composition, and sequence compared with the LHX3a-specific domains. Compared with the human LHX3 isoforms, the LHX3b-specific domains are ϳ93% identical across species, whereas the LHX3a-specific domains are ϳ52% identical.
Lhx3a and Lhx3b Are Differentially Expressed in Rodent Cell Lines Representing Pituitary Cell Lineages-We previously have used RT-PCR to show that
Lhx3a is highly expressed in the ␣TSH cell line (5) and now demonstrate that high levels of this isoform also were present in ␣T3-1 cells (Fig. 1, B and C) . The ␣TSH and ␣T3-1 cell lines are used to study pituitary thyrotrope and gonadotrope function, respectively (15) . Both cell lines express the ␣GSU gene that codes for the common ␣ subunit of TSH, luteinizing hormone, and follicle-stimulating hormone. Interestingly, previous reports have demonstrated that LHX3a can trans-activate the ␣GSU gene in transfection assays (5, 13, 16 -18) . The high levels of Lhx3a in cell lines representing the glycoprotein hormone pituitary lineages are consistent with ␣GSU being a LHX3a target gene. Additionally, low levels of Lhx3a expression were found in the mammosomatotrope GC (19) and lactotrope 235 (20) cell lines (Fig. 1 , B and C). By contrast, high levels of Lhx3b expression occurred in cell lines representing the gonadotrope (␣T3-1), lactotrope (235), mammosomatotrope (GC), and thyrotrope (␣TSH) lineages ( Fig. 1 , B and C). We have been unable to detect Lhx3 isoform expression in the GHFT1 cell line that represents an undifferentiated precursor pituitary cell type, and only trace amounts of Lhx3b expression are observed in AtT20 corticotrope cells (5) . These data are consistent with Lhx3 gene products being required for the differentiation of all of the anterior pituitary hormone-secreting cell types except corticotropes (8) .
The LHX3b-specific Domain Inhibits Gene Activation of HD Transcription Factors-To examine the regulatory properties of the alternate LHX3 amino-terminal domains, we generated expression vectors coding for LHX3a/b-chimeric proteins. Transfer of the a-and b-specific domains to the LHX3a, LHX3b, PROP-1, LHX4, and TEF transcription factors enabled detailed functional analyses of these domains in gene trans-activation assays. Transfer of the LHX3b-specific domain to LHX3a reduced its ability to activate the ␣GSU promoter (Fig. 2, A and B) and a minimal promoter reporter gene containing an LHX3-consensus binding site (data not shown). Importantly, transfer of the LHX3a-specific domain to LHX3b did not induce an ability to activate transcription of these reporter genes, and removal of either amino-terminal domain (⌬N-LHX3) resulted in a molecule with similar (or increased) activity to that of LHX3a (Fig. 2B ). Western analysis confirmed expression of the LHX3 chimeric proteins in these assays and also identified an abundant, faster migrating species in LHX3a and ⌬N-LHX3 experiments (Fig. 2C , and see below). Trace amounts of this smaller LHX3 protein were observed in assays examining LHX3b, b-LHX3a, and a-LHX3b only after extended exposure of films (data not shown).
Transfer of the LHX3b-specific domain to the related LHX4 LIM HD protein and to the PROP-1 paired-class HD transcription factor inhibited the trans-activation capabilities of these factors (Fig. 3, A and B) . This is the first report to show LHX4 activation of the ␣GSU gene (Fig. 3B) . Similarly, transfer of the b-specific domain to PROP-1 (b-PROP-1) reduced its ability to activate the paired-class PRDQ 9 (10, 21) reporter gene (Fig.  3A) . Transfer of the LHX3a-specific domains to PROP-1 and LHX4 had modest effects on their function (Fig. 3, A and B) . Transfer of the LHX3a-or LHX3b-specific domains to the proline and acidic amino acid-rich domain basic region leucine zipper transcription factor TEF did not inhibit the function of this class of regulatory protein (Fig. 3C ). Together, these results demonstrate that the LHX3b-specific domain is a transferable domain that reduces the activity of HD transcription factors.
The LHX3b-specific Domain Inhibits DNA Binding of HD Transcription Factors-To determine the mechanism by which the LHX3b-specific domain negatively regulates transcriptional activation, we tested the ability of the LHX3a/b-chimeric proteins to bind specific DNA elements using EMSAs. First, in vitro translated LHX3a, LHX3b, a-LHX3b, b-LHX3a, and ⌬N-LHX3 proteins were examined (Fig. 4, A and B) . In these experiments, LHX3a and ⌬N-LHX3 bound more strongly to the PGBE compared with LHX3b, a-LHX3b, and b-LHX3a (Fig.  4B) . These results demonstrated that transfer of the LHX3b-specific domain to LHX3a inhibited its ability to bind DNA. As observed in the LHX3 Western blots shown in Fig. 2C , a faster migrating protein was present in LHX3a and ⌬N-LHX3 protein translations (Fig. 4A ), while this protein was only detected at trace levels in LHX3b, b-LHX3a, and a-LHX3b translations following extended film exposures (data not shown). Interestingly, EMSA analysis revealed the presence of an intense, faster migrating protein-DNA complex in the LHX3a and ⌬N-LHX3 reactions and a faint complex at this migratory position in LHX3b, a-LHX3b, and b-LHX3a reactions (Fig. 4B) . To further characterize the regulatory properties of the a-and bspecific domains, we expressed recombinant LHX3 chimeric proteins in E. coli as fusions to the carboxyl terminus of GST. EMSA reactions using equivalent amounts of these purified proteins gave similar results to the data obtained with the in vitro translated proteins; transfer of the b-specific domain to LHX3a (GST-b-LHX3a) reduced binding of this molecule to DNA (data not shown). In summary, the b-specific domain inhibited binding of LHX3 to DNA regulatory sites. Additionally, transfer of the a-specific domain to LHX3b did not relieve the b-specific domain inhibitory effect. Removal of the a-and b-specific domains from LHX3 enabled binding of this protein to DNA sites similar to LHX3a binding.
Transfection assays demonstrated that transfer of the LHX3b-specific domain to PROP-1 (b-PROP-1) inhibited the ability of PROP-1 to activate a reporter gene (Fig. 3A) . To examine the mechanism responsible for this inhibition, we generated in vitro translated LHX3a/b-PROP-1 chimeric pro- teins (a-PROP-1, b-PROP-1) and performed EMSA experiments with a PRDQ 9 DNA element (Fig. 4, C and D) . Similar to transfer of the b-specific domain to LHX3a, the b-specific domain inhibited the ability of PROP-1 to bind DNA (Fig. 4D) . In these assays, transfer of the a-specific domain to PROP-1 (a-PROP-1) also reduced PROP-1 DNA binding, although not to the extent of the b-specific domain transfer (Fig. 4D) . Consistent with the transfection data, these results provide evidence that the LHX3b-specific domain negatively regulates LHX3 function by preventing HD binding to specific DNA regulatory elements.
Identification of a Novel LHX3 Protein-Our studies indicate the presence of an uncharacterized, faster migrating LHX3 species in Western blots of extracts from cells transfected with LHX3a and ⌬N-LHX3 expression vectors, but not LHX3b vectors (Fig. 2C) . Because the carboxyl terminus of LHX3a was fused to a Myc epitope in these studies, Western experiments using an anti-Myc antibody indicated that the faster migrating LHX3 protein lacks amino-terminal residues. In addition, we observed a faster migrating protein form in in vitro translations of the Lhx3a and ⌬N-Lhx3 cDNAs (Fig. 4A) , and a more pronounced, rapidly migrating protein-DNA complex in EMSA reactions containing in vitro translated LHX3a and ⌬N-LHX3 proteins (Fig. 4B, closed arrow) . Because the lower molecular weight LHX3 molecule was generated in transfection experiments and in in vitro translation reactions featuring expression of cDNAs (LHX3a and ⌬N-LHX3), we suspected that this protein was formed by a post-transcriptional mechanism and not by alternative RNA splicing. In some studies, we used LHX3a and LHX3b cDNA expression vectors containing the 5Ј-untranslated sequences unique to each isoform (Fig. 5A) . To determine whether translation initiation of the LHX3 isoforms was regulated by these upstream regions, we performed assays with expression vectors without these sequences (Figs. 2C and 5B). In both cases, significantly higher amounts of the faster migrating LHX3 protein were present in cells expressing Lhx3a cDNAs compared with Lhx3b cDNAs. These observations suggest that the generation of this alternate, smaller form of LHX3 is inhibited by the Lhx3b-specific sequence.
To further characterize the production of the smaller LHX3 protein, we performed time-course experiments to examine the accumulation of this LHX3 species (Fig. 5B) . If the faster migrating LHX3 protein accumulated over time at the expense of the slower migrating protein, we would suspect that the production of this LHX3 molecule must result from proteolytic processing of full-length LHX3a. However, because the proteins accumulated at similar rates (Fig. 5B) , we examined the LHX3a coding sequence for the presence of potential alternate AUG translation initiation sites. In addition, we compared the migratory position of a LHX3 protein lacking the amino terminus and both LIM domains (⌬LIM LHX3, removal of amino acids 1-149 of 397) with the migration of this uncharacterized LHX3 species. These experiments demonstrated that the newly identified LHX3 protein migrates with a slightly higher apparent molecular weight than that of the ⌬LIM LHX3 (data not shown) and enabled us to hypothesize that this novel LHX3 protein results from the use of an alternate methionine (Met) initiation codon. Examination of the Lhx3a cDNA sequence revealed the presence of a potential in-frame ATG translation start site at position 134 of the LHX3a protein. Consistent with the hypothesis, site-directed mutagenesis of Met-134 of LHX3a (LHX3a mutM2) eliminated the production of the faster migrating LHX3 protein (Fig. 6A) . In addition, mutation of the primary LHX3a and LHX3b start codons (LHX3a/b mutM1) led to the production of only this lower migrating LHX3 species. Further, this protein resolved to the same position as a protein generated by an expression vector encoding only amino acids 134 -397 of LHX3a (Fig. 6A) . We refer to this novel form of LHX3 as M2-LHX3. Interestingly, this Met (134 in LHX3a, 139 in LHX3b) is conserved in several LIM HD transcription factors and may represent a mechanism utilized by these factors to produce multiple protein isoforms with different gene regulatory capabilities (Fig. 6B) . Indeed, Western analyses of cells transfected with a mouse LHX4 expression vector indicated the presence of a faster migrating protein that appears to result from alternate translation initiation by Met-110 (Fig. 6C) .
Translation of the M2-LHX3 Protein Is Regulated by the LHX3b-specific Coding Sequence-We initially observed that the M2-LHX3 protein was present in extracts from cells transfected with LHX3a expression vectors, whereas only trace amounts of this protein were found in assays examining LHX3b function. Transfer of the LHX3b-specific coding sequence to LHX3a dramatically decreased the production of the M2-LHX3 protein (Fig. 2C) . Additionally, deletion of the b-specific domain sequence (⌬N-LHX3) allowed generation of high amounts of the M2-LHX3 species (Figs. 2C and 6A) . Further, transfer of the LHX3b-specific coding sequence to LHX4 strikingly reduced the production of the M2-LHX4 protein (Fig. 6C) .
The M2-LHX3 Protein Is Present in Pituitary Cells-After characterizing the differential production of M2-LHX3 in transfection assays, we wished to determine the presence of this protein in pituitary cells. We chose to assess expression of the M2-LHX3 protein in the ␣TSH cell line because we have demonstrated that this cell line expresses high levels of Lhx3a mRNA (5) . The available anti-LHX3 antisera did not allow effective detection of LHX3 molecules in extracts from these cells in Western experiments (data not shown). However, EMSA analysis of ␣TSH cell extracts indicated that multiple complexes bound to both the ␣GSU PGBE and the LHX3 consensus binding sites (Fig. 7, A and B) . These experiments were performed in parallel with EMSA reactions comprising protein extracts from 293T cells transfected with LHX3a-Myc, LHX3b-Myc, or M2-LHX3-Myc expression vectors. Comparison of the migratory positions of bound complexes revealed the presence of a complex in the ␣TSH reaction that resolved to a similar position to that of the M2-LHX3-Myc complex (Fig. 7, A and B) . Importantly, this complex was specifically disrupted by an anti-LIM-3/LHX3 antibody, indicating that the M2-LHX3 protein is present in ␣TSH cells. Similar data were obtained in experiments using the anti-Myc epitope antibody to characterize the M2-LHX3 protein in transfected cells (data not shown). Because the M2-LHX3 isoform lacks the LIM domains (which have been demonstrated to inhibit DNA binding of many LIM HD proteins (see Refs. 13, 16, and 22)), it displays an increased binding to these DNA sites (see below) and is, therefore, more readily detected than the full-length LHX3 molecule in these assays. Together, these experiments demonstrate that the faster migrating LHX3 protein originates from an alternate start methionine, and that this LHX3 protein is present in LHX3a-expressing pituitary cells.
M2-LHX3 Activates the TSH␤ and PRL Genes-To test the function of M2-LHX3, we performed transfection assays to examine the ability of this protein to activate the ␣GSU, PRL, and TSH␤ genes. Previous studies have shown that LHX3a can activate the ␣GSU gene alone and the PRL and TSH␤ genes in synergy with the PIT-1 POU HD protein (5, 13, 16 -18, 23) . Assays performed here indicate that the M2-LHX3 protein has a reduced ability to activate the ␣GSU gene (Fig. 8A ) but can synergize with PIT-1 to induce transcription of the PRL and TSH␤ promoters (Fig. 8, B and C) .
M2-LHX3 Displays an Increased Ability to Bind DNA and Contains the Major LHX3
Transcriptional Activation Domain-To determine the mechanism by which M2-LHX3 induces transcription, we characterized its DNA binding and gene activation properties. EMSA experiments using purified, recombinant LHX3 proteins demonstrate that M2-LHX3 bound with greater affinity to the LHX3 consensus site than LHX3a or LHX3b (Fig. 9, A-C) . The M2-LHX3 protein does not contain the amino-terminal LIM domains, and this result is consistent with previous reports describing the inhibitory nature of the LIM domains of some LIM HD proteins in DNA binding (13, 16, 22) . A previous study has mapped a trans-activation domain in the second LIM domain of LHX3 (17) . Most of this domain was absent from the M2-LHX3 protein. We therefore hypothesized that additional activation domains must be present. A systematic search for activation domains in all regions of the LHX3 protein isoforms was performed by assaying the transcriptional activity of LHX3 domains fused to the Gal4 DNA binding domain (Gal4-DB; Fig. 9, A and D) . A sequence in the carboxyl terminus of LHX3 (referred to as the C2 region) was identified as the major activation domain. Deletion of the C2 domain from M2-LHX3 impairs its ability to activate the PRL promoter (Fig.  9E) . Together, these data demonstrate that the M2-LHX3 molecule is capable of binding DNA regulatory elements and requires a trans-activation domain within its carboxyl terminus to induce transcription. 
FIG. 7. M2-LHX3 is expressed in pituitary cells.
A, an EMSA using a LHX3 consensus binding site probe was performed with nuclear extracts of either human kidney 293T cells transfected with LHX3 expression vectors or extracts of mouse pituitary ␣TSH cells. Radiolabeled probe was incubated with the indicated extracts and the resulting complexes were separated from free probe (f) by electrophoresis. Anti-LIM-3/LHX3 antibody (␣LHX3) was added to some reactions. M2-LHX3-DNA complexes are indicated by an arrow. B, EMSA using an ␣GSU promoter PGBE probe.
DISCUSSION
Gene regulatory proteins play critical roles in developmental and cellular homeostatic processes. Many reports have described transcription factor genes that code for multiple protein isoforms. For example, alternate forms of PITX2 (24, 25) , PIT-1 (26), LHX6 (27) , SKN-1 (28), EGR3 (29) , and PPAR␥ (30, 31) have been described. The production of additional proteins by alternative RNA splicing, multiple promoter usage, and alternate use of translation initiation codons enables expansion of the regulatory capacity of a single gene. For example, human PITX2 isoforms possess identical HDs and carboxyl termini but have different amino-terminal sequences that are generated by alternative splicing and the use of two promoters (32, 33) . PIT-1 isoforms, which contain insertions of 14 and 26 amino acids in the amino-terminal trans-activation domain, also are generated by alternative splicing (26) . In addition, a shorter PIT-1 protein is formed by the use of an alternate translation initiation codon (34) . In several cases, transcription factor isoforms have been shown to possess different gene regulatory functions. SKN-1a and SKN-1i are POU HD factors expressed in the developing epidermis that possess unique amino-terminal domains generated by alternative splicing. Transfection assays demonstrate that SKN-1a can induce transcription from the cytokeratin 10 gene whereas SKN-1i cannot (28) . Similarly, PITX2 isoforms in zebrafish have distinct patterns of expression and play unique roles during mesendoderm and asymmetric organ development (35) . Previously, it has been shown that two LHX3 isoforms, LHX3a and LHX3b, are generated from the Lhx3 gene, and that these factors differ only at their amino termini (4 -7). Lhx3 isoform expression experiments in mice (4), analysis of differential Lhx3 expression patterns in rodent pituitary cell lines ( Fig. 1 and Ref. 5) , and the identification of conserved gene regulatory elements in the mouse and human Lhx3 genes (4, 6) suggest that these proteins are generated by the use of two promoters. The studies presented here examine the amino acid conservation, pituitary cell type expression, and functional characteristics of alternate LHX3 proteins. In addition, we identify a third LHX3 protein, which is generated by the use of an internal translation initiation site.
Lhx3 knockout mice do not develop a mature pituitary gland and only form a few corticotrope cells, suggesting that the Lhx3 gene is required for the differentiation of the gonadotrope, lactotrope, somatotrope, and thyrotrope cell lineages (8) . Similarly, patients with LHX3 gene mutations are deficient in each of the anterior pituitary hormones except adrenocorticotropin (9) . To gain insight into which LHX3 isoform is critical for differentiation of each pituitary cell type, we examined rodent pituitary cell lines for the presence of Lhx3a and Lhx3b. Differential expression of the isoforms in these cell lines suggests the factors play different gene regulatory roles in the development of the distinct cell types. Consistent with previous reports describing activation of the ␣GSU gene by LHX3a (5, 13, 16 -18) , Lhx3a expression was identified in cell lines representing the gonadotrope and thyrotrope lineages. Although genes specifically regulated by the LHX3b isoform have yet to be identified, Lhx3b expression in cell lines representing the gonadotrope, lactotrope, somatotrope, and thyrotrope lineages is consistent with data from the Lhx3 null mice and suggests important functional roles for this factor in regulation of genes critical to development of these cells. Analysis of the alternate a-and b-specific amino-terminal domains in several mammalian species reveals that the amino acid sequence of the b-specific domain is more highly conserved than the a-specific domain. Together, the broad pattern of LHX3b pituitary cell type expression and the high degree of b-specific domain amino acid conservation suggest the LHX3b isoform is critical to anterior pituitary gland formation.
We have shown previously that the LHX3b-specific domain prevents LHX3 from activating the ␣GSU gene by inhibiting its binding to the PGBE (5) . To further characterize the intrinsic regulatory function of this domain, we transferred the LHX3b-specific domain to related and unrelated DNA regulatory proteins. Transfer of the b-specific domain to LHX3a, LHX4, and PROP-1 impairs the trans-activation capabilities of these HD proteins. However, transfer of this domain to the non-HD proline and acidic amino acid-rich domain basic region leucine zipper transcription factor TEF does not affect its ability to activate the TSH␤ gene. This contrasts with experiments where transfer of the amino-terminal SKN-1i domain to TEF inhibits its function by preventing DNA binding (28) . Importantly, transfer of the LHX3a-specific domain to LHX3b did not confer the ability to activate the tested LHX3a-responsive genes. Transfer of the LHX3b-specific domain to HD-containing proteins, such as LHX3a and PROP-1, inhibits the DNA binding ability of these molecules. The inhibitory nature of the b-specific domain appears to be an intrinsic mechanism that prevents DNA binding of a HD protein. Although corepressor proteins may interact with the LHX3b-specific domain to prevent gene trans-activation, EMSAs using purified LHX3 chimeric proteins suggest that the b-specific domain imparts structural constraints upon these factors that impair HD accessibility to target DNA elements. We previously have demonstrated that LHX3b operates similarly in both pituitary and heterologous cells (5, 18) . However, it also is possible that pituitary-specific coactivator or corepressor proteins interact with the LHX3b-specific domain in a highly coordinated fash- ion to enable function of this isoform during pituitary development.
An active, short isoform (M2-LHX3) is produced from the LHX3 gene. This is the first study to identify this type of protein product from a LIM HD gene. We demonstrate that this protein is generated by the use of an internal start methionine at codon 134 (AUG 134 ) in LHX3a. Interestingly, the conserved b-specific sequence restricts usage of this translation initiation codon. One of the important Kozak translation initiation consensus residues is a G at the ϩ4 position (36) . Sequence analysis reveals the first LHX3b AUG (M1) contains a G at this position, whereas LHX3a M1 has a less favorable C at this site. Examination of the ϩ4 position of the LHX3 isoforms from mammalian species identified in this study shows strict conservation of the G and C residues in the Lhx3b and Lhx3a sequences, respectively. We suggest, that without a G at the ϩ4 position, leaky ribosomal scanning of the LHX3a M1 occurs, which allows usage of AUG 134 and production of the M2-LHX3 protein. Indeed, the first translation initiation site in the mouse Lhx4 mRNA also does not contain a G at this position, which may allow production of the M2-LHX4 protein.
A similar mechanism appears to enable generation of multiple PIT-1 (34) and EGR3 transcription factor (29) isoforms.
The M2-LHX3 protein is present in the ␣TSH cell line and can bind to the PGBE located in the ␣GSU gene. This element is required to correctly restrict expression of the ␣GSU gene to pituitary gonadotropes and thyrotropes (37) . LHX2 and LHX3 previously have been shown to specifically bind to the PGBE in EMSA experiments (11, 13, 23) . Several of these studies demonstrate that multiple complexes bind to the PGBE in experiments using protein extracts from pituitary cell lines (11, 23) . It has been suggested that the unidentified complexes contain LHX2 or LHX3 and different combinations of LHX2/LHX3-interacting proteins (23) . However, these complexes have not been disrupted or characterized with antibodies against LHX2/ LHX3-interacting proteins such as NLI, SLB, or MRG1 (11, 23) . Our data suggest that the EMSA complexes described in these previous reports may be composed of full-length LHX2 or LHX3a in the higher migrating complexes and M2-LHX3 (or M2-LHX2) in the lower migrating complexes. In addition, the alternate translation initiation codon identified in this study is conserved in other LIM HD transcription factors and may be utilized to expand the regulatory properties of these genes. Indeed, our experiments demonstrate that this mechanism enables the production of a M2-LHX4 isoform.
M2-LHX3 is capable of binding DNA regulatory elements and inducing gene transcription because this molecule contains the major LHX3 trans-activation domain. However, the functional significance of the M2-LHX3 and M2-LHX4 proteins is unclear. Although it has been technically challenging to detect M2-LHX3 proteins in pituitary cell extracts using available antisera (data not shown), the increased DNA binding capacity of M2-LHX3 suggests that it may play important regulatory roles. Indeed, the M2-LHX3 molecule can synergize with PIT-1 to activate the PRL and TSH␤ genes. Importantly, this activity requires a novel activation domain (C2) located within the carboxyl terminus. Identification of the C2 domain provides an explanation of data described in previous reports showing that LHX3a proteins with pituitary disease-causing LIM2 mutations still retain some ability to synergize with PIT-1 to activate the PRL promoter (18, 23) . Alternately, because the M2-molecules do not contain intact LIM domains that are required for some LIM HD functions (9, 18, 23) , these forms of the LHX3 and LHX4 proteins might play dominant negative regulatory roles. In transfection assays, the M2-LHX3 has a reduced ability to activate the ␣GSU promoter, a result similar to experiments examining the functions of LHX2 and LHX3 molecules with mutated or deleted LIM domains (13, 17, 18 ). M2-LHX3 A) were fused to the Gal4-DB, and the resulting expression vectors were tested for their ability to activate a luciferase reporter gene containing five upstream activating sequence (UAS) elements in transfections of human 293T cells. The LIM domains have some activation function, but the major transactivation domain (C2) is in the carboxyl terminus. A representative experiment of at least three experiments is depicted. E, the C2 trans-activation domain is required for M2-LHX3 transcriptional synergy with Pit-1. Expression vectors encoding truncations of M2-LHX3 were generated. 293T cells were transfected with a PRL enhancer/promoter luciferase reporter gene and the indicated expression vectors. Promoter activity was assayed as described in Fig. 1 . A representative experiment of at least four experiments is depicted.
does not contain the LIM2 trans-activation domain (17) that appears to be important for LHX3a ␣GSU induction. However, the C2 activation domain located within the carboxyl terminus is required to regulate the PRL gene. This domain also is necessary for activation of the ␣GSU promoter. 2 The LHX3 molecule therefore contains multiple activation domains that are required for distinct activities.
The studies presented in this report describe mechanisms utilized by specialized cell types to produce multiple regulatory proteins with distinct functions from a single gene. Elaborate regulation of the LHX3 gene at the levels of transcription and translation expands the functional capacity of this gene by generating at least three protein isoforms. Understanding LHX3 isoform expression and function furthers our knowledge of the pituitary cell proteome and suggests that these factors play distinct roles during mammalian pituitary development and function.
